Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
MPC Therapeutics logo — Biotech company focused on cellular rejuvenation to fight ca...

MPC Therapeutics

Biotech company focused on cellular rejuvenation to fight cancer & degenerative pathologies.

Founded 2018 Switzerland Plan-les-ouates, Switzerland 6 employees Debt Financing Total: $2.66M Biotechnology, Health Care

General Information

Company Name MPC Therapeutics
Founded Year 2018
Location Switzerland Plan-les-ouates, Switzerland +1
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

Get notified when MPC Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MPC Therapeutics

MPC Therapeutics is a biotech company focused on cellular rejuvenation to combat cancer and degenerative pathologies. Headquartered in Switzerland and founded in 2018, the startup is harnessing the potential of mitochondria as therapeutic targets. Their innovative approach involves proprietary first-in-class small molecules that specifically target mitochondria to induce metabolic reprogramming. MPC Therapeutics aims to enhance the efficacy of cell therapies and address degenerative pathologies through their pioneering techniques. The company recently received a Fr.100.00K debt financing investment on 16 November 2023 from the FONGIT Innovation Fund. This infusion of capital underscores the confidence of investors in MPC Therapeutics' vision and technology. As MPC Therapeutics continues to make strides in the biotechnology and healthcare sectors, their commitment to leveraging mitochondria for cellular rejuvenation holds great promise in the fight against cancer and degenerative diseases. For more information, visit their website.

Taxonomy: Biotech, Cellular Rejuvenation, Mitochondria, Metabolic Reprogramming, Cell Therapies, Cancer Treatment, Degenerative Pathologies, Small Molecules, Therapeutic Targets, Switzerland, Startup, Healthcare Innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1 •••• •••• 16 Nov 2023
Seed Round •••••• 1 •••• •••• 10 Jan 2023
Grant •••••• - 01 Nov 2020
Grant •••••• 1
Investor
01 Jul 2019
Grant •••••• 1
Investor
04 Jun 2019

View All 6 Funding Rounds

Latest News

View All
Small country, big ambitions: What Nexus Luxembourg 2026 revealed about Europe’s tech future — Tech
Small country, big ambitions: What Nexus Luxembourg 2026 revealed about Europe’s tech future
Tech Jun 24, 2026

MPC Therapeutics Alternatives & Competitors

MPC Therapeutics vs
cellvie
cellvie Switzerland

Levearging the therapeutic potential of mitochondria

Seed
11 employees
Biotechnology, Health and Wellness
MPC Therapeutics vs
Mitoimmune Therapeutics Inc.
Mitoimmune Therapeutics Inc. Korea South

"Mighty Mitochondria For a Healthier Life!"

Series B
6 employees
Biotechnology, Pharmaceutical
MPC Therapeutics vs
Vincere Biosciences
Vincere Biosciences United States

Relentless pursuit of therapeutics that slow/stop the progression of age-related disease

Corporate Round
11 employees
Biotechnology

FAQ About MPC Therapeutics

Biotech company focused on cellular rejuvenation to fight cancer & degenerative pathologies.
MPC Therapeutics was founded in 2018.
MPC Therapeutics is headquartered in Plan-les-ouates, Switzerland.
MPC Therapeutics operates in the following industries: Biotechnology, Health Care.
MPC Therapeutics has approximately 6 employees.
MPC Therapeutics has completed 6 funding rounds, raising a total of $2.66M. The latest funding stage is Debt Financing.
Top alternatives and competitors to MPC Therapeutics include cellvie, Mitoimmune Therapeutics Inc., Vincere Biosciences, Mito BioPharm, Pretzel Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MPC Therapeutics and cellvie are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MPC Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy